These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10459888)

  • 1. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
    Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
    Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives.
    Hsu HC; Lin RS; Tung TH; Chen TH
    Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of routine childhood varicella vaccination in Germany.
    Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
    Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instituting a routine varicella vaccination program in Canada: an economic evaluation.
    Getsios D; Caro JJ; Caro G; De Wals P; Law BJ; Robert Y; Lance JM
    Pediatr Infect Dis J; 2002 Jun; 21(6):542-7. PubMed ID: 12182379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
    Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of varicella vaccine programs for Australia.
    Scuffham PA; Lowin AV; Burgess MA
    Vaccine; 1999 Oct; 18(5-6):407-15. PubMed ID: 10519929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of varicella vaccination of healthcare workers.
    Chodick G; Ashkenazi S; Livni G; Lerman Y
    Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
    Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers.
    Nettleman MD; Schmid M
    Infect Control Hosp Epidemiol; 1997 Jul; 18(7):504-8. PubMed ID: 9247834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluations of varicella vaccination programmes: a review of the literature.
    Thiry N; Beutels P; Van Damme P; Van Doorslaer E
    Pharmacoeconomics; 2003; 21(1):13-38. PubMed ID: 12484801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness of varicella vaccination in Spanish adolescents].
    Peña-Rey I; Pérez-Farinós N; Cortés-García M; Amela-Heras C
    Gac Sanit; 2004; 18(4):287-94. PubMed ID: 15324639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of varicella vaccination in Canada.
    Brisson M; Edmunds WJ
    Vaccine; 2002 Jan; 20(7-8):1113-25. PubMed ID: 11803072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.